Notably, the number of γH2AX/53BP1 foci in PBMCs increased across the spectrum from CP-CML towards BP-CML patients, suggesting the promotion of erroneous NHEJ and MMEJ during blastic transformation. This evidence concerns the gene TP53BP1 and chronic myelogenous leukemia, BCR-ABL1 positive.